Sergio Traversa - 17 Dec 2021 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Executive Officer, Director
Signature
/s/ Sergio Traversa
Issuer symbol
RLMD
Transactions as of
17 Dec 2021
Net transactions value
$0
Form type
4
Filing time
21 Dec 2021, 20:31:14 UTC
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +492,173 $0.000000 492,173 17 Dec 2021 Common Stock 492,173 $19.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 16 equal quarterly installments commencing on March 17, 2022.